R3i - Residual Risk Reduction Initiative The R3i, a worldwide, academic, multidisciplinary non-profit organization, aims to successfully address the excessively high risk of macro- and microvascular complications in patients with atherogenic dyslipidemia, characterized by elevated triglycerides and low levels of high- density lipoprotein (HDL) cholesterol and unaddressed by current standards of care. Visit us at www.r3i.org/